Tag: Medical Therapy

January 27th 2017
Share:

CDP at MD&M West 2017 in Anaheim

Cambridge Design Partnership is exhibiting at Medical Device and Manufacturing West (MD&M West) in Anaheim, California from 7th – 9th February this year.

Our booth is number is 1425 in the Electronics West zone. Details on how to find us.

MD&M West is the world’s largest medical design and manufacturing event, with leading medical design experts attending to network and showcase latest innovations in medical device design and manufacturing.

Exhibiting for the fifth year running, Cambridge Design Partnership will have live demonstrations on its booth of two connected devices, the multi-award-winning – First Response Monitor and diialog™.

A number of our sector experts will attending MD&M West 2017 including:

Alan Cucknell, Front End Innovation Leader
Alan is a seasoned innovation professional. His systematic, evidence based approach builds on his formal engineering education and nearly fifteen years’ experience tackling strategic business and technology challenges. Alan will be happy to discuss your innovation challenges and suggest new approaches to help you achieve success.

James Baker, Senior Electrical Engineer and CDP Partner
James is a chartered engineer with a Master’s Degree in electronic engineering. He leads the connectivity and electronics capabilities at CDP, applying his experience to projects covering all forms of sensing, communications and wearable technologies. James can advise you on developing healthcare products that feature complex embedded functionality and are simple to use.

Dr Jez Clements, Senior Mechanical Engineer and CDP Partner
Jez is a professional engineer with a PhD in orthopaedic implants. He has led several major medical device development programs across diagnostics and drug delivery. Jez helps clients overcome tough engineering challenges and will be happy to discuss how CDPs capabilities can help accelerate your development portfolio.

Dr Dom Freeman, US Business Leader
Dom has over 30 years’ experience in the medical device design, with deep knowledge of the blood glucose monitoring market and magnetic resonance imaging. She is also an expert in IP strategy. Dom will be available to discuss how outsourcing product innovation and engineering development can benefit your business and overcome key challenges to growth.

To arrange a meeting during MD&M West, please get in touch.

We hope to see you in Anaheim.

January 10th 2017
Share:

IMPLEMENTING MEDICAL DEVICE CYBERSECURITY James Baker is guest columnist on Med Device Online

Connectivity is ubiquitous – it’s moved beyond an overhyped buzzword and become part of life. Offering ever-advancing levels of access, control, and convenience, widespread connectivity also increases the risk of unauthorised interference in our everyday lives.

In what many experts believe was a world first, manufacturer Johnson & Johnson recently issued a warning to patients on a cyber-vulnerability in one of its medical devices. The company announced that an insulin pump it supplies had a potential connectivity vulnerability. The wireless communication link the device used contained a potential exploit that could have been used by an unauthorised third party to alter the insulin dosage delivered to the patient.

It’s not hard to imagine the devastating impact to both consumers and the company if the reported vulnerability had been exploited. However, risks such as security will not prevent evolution of connected devices – demand for ever-increasing levels of convenience and access are driving the continued evolution and adoption of these products and services.

Cyber-security considerations shouldn’t be viewed as stumbling blocks for the connected device concept. Rather, it’s another of the many product requirements which, if considered and specified correctly at the design stage, can be implemented robustly. Above all, cybersecurity can be validated as part of a wider-reaching regulated device development process. It can’t be considered an isolated element to be bolted on, since it inherently helps to define the system architecture of what is developed.

Read full article.

ablation-catheter-technology-cardiology
August 4th 2016
Share:

CDP and Kings College London develop innovative steerable catheter to treat cardiac arrhythmia

Innovative design and technology consultancy Cambridge Design Partnership has worked with King’s College London to develop a novel steerable catheter which King’s researchers had designed.  The catheter is designed to improve the treatment of cardiac arrhythmia – a range of conditions which can lead to stroke or heart failure that affects 2 million people a year1 in the UK alone.

The new steerable, micro moulded catheter enables targeted delivery of radio frequency energy to specific points in the heart tissue for corrective treatment. Compared with traditional catheters, the new device has been designed to be quicker and easier to manoeuvre into the correct position, improving the accuracy of positioning and minimising damage to healthy tissue, which should improve success rates of the treatment.

Cambridge Design Partnership won a four-way competitive bid to further develop the device created by King’s College London, involving helix-shaped interlocking tubes that would allow improved steerability and greater compatibility for robotic control over other catheters on the market. The team at Cambridge Design Partnership successfully refined the initial design, enabling the device to meet key regulatory and biocompatibility requirements, whilst ensuring suitability for commercial manufacture. Through CDP’s experience of developing highly technical medical devices, the team was able to miniaturise the design to allow improved space for the delivery of ablation energy and irrigation. The new catheter design is also assembled from micro injection moulded sections, incorporating features that enable the device to be built on an automated assembly line at reduced manufacturing cost.

Matt Brady, head of Medical Therapy, Cambridge Design Partnership, said: “The steerable catheter is an extraordinary product, with innovative features that enable corrective treatment to be delivered to very specific areas of the heart. By enabling greater accuracy and quicker treatment time, we believe it is possible to preserve more healthy heart tissue, and increase the success of the treatment. It’s been hugely exciting to be involved in this joint project with King’s College London and use our expertise to bring such an innovative product one step closer to commercial use.”

Professor Kawal Rhode, Professor of Biomedical Engineering at King’s College; London, commented: “We have been delighted with the results of Cambridge Design Partnership’s work on this project. The team was chosen for the strength of their existing experience in developing catheters across both start-ups and global corporations.  We were very pleased with the engineering approach and practical improvements that they managed to incorporate. They delivered fully moulded parts, and specified other components and the assembly route which fully met our aspirations for the project.”

King’s College London is now undertaking extensive lab testing of the catheter device, with clinical trials expected to be take place in two to three years.

1 Arrhythmia

For further information on this project, please email: hello@cambridge-design.co.uk

For Enquiries to King’s College London:
Please contact Dr. Rob Glen, King’s Commercialisation Institute
Robert.glen@kcl.ac.uk 020 7188 6209
Kings Commercialisation Institute

October 16th 2014
Share:

AAMI human factors for medical devices course returns to Europe

Innovative technology and design consultancy Cambridge Design Partnership today announced that due to the huge success of Europe’s first AAMI Human Factors for Medical Devices course they will be sponsoring more courses in 2015.

Cambridge Design Partnership worked with the US based Association for the Advancement of Medical Instrumentation (AAMI) and Pure Insight to bring the course to Europe for the first time in April 2014 and the course was hugely oversubscribed. In response to demand from medical device development companies, which deem the course content as a ‘must have’ piece of knowledge for their medical device development teams, a course has been scheduled for January 2015.

Cambridge Design Partnership have recognised the importance of Usability Engineering in medical device development programmes for many years and are keen to share this enthusiasm with the wider development community by teaming up with AAMI and Pure Insight to bring this definitive course to Europe.

This course delivers practical Usability Engineering techniques that can be implemented in any medical device development programme and gives insights into creating usability submissions for both the USA and the EU regulatory regimes.  With new guidelines proposed in the US, medical device companies worldwide need to be vigilant in understanding how to navigate these changing regulatory landscapes. The AAMI course not only addresses Usability Engineering itself, it also looks at the growing harmonisation between global standards, streamlining device submissions.

The course leaders are the highly regarded Dr. Ed Israelski who is the convener of international HF medical standards with IEC and ISO and Dr. Robert North, who is a co-author of the FDA human factors standards. This course is exclusively the only event held in Europe where companies can talk directly to an FDA representative who hosts a question and answer session and gives delegates the benefit of the latest insight into streamlining submissions as well as common submission errors and deficiencies.

“At CDP our experience developing novel medical devices shows us that effective Usability Engineering is crucial to commercial success, not only to meet regulatory requirements but to enable new products to succeed in a competitive marketplace. When developing fast moving consumer products companies naturally place the user at the centre of the design process,  but when it comes to safety critical medical devices sometimes the complex technical and clinical requirements overshadow basic patient needs. This course explains the processes you can use to ensure your devices are easy and safe for patients to use.  Medical device manufacturing companies must demonstrate this to the regulators and this course explains how this is achieved.” Comments Mike Cane, Founder, Cambridge Design Partnership.

Cambridge Design Partnership is a leading technology and product design partner focused on helping its client’s businesses grow. Some of the world’s largest companies trust CDP to develop their most important innovations.

Cambridge Design Partnership specialises in the healthcare, consumer, energy and industrial equipment markets and its multidisciplinary staff have the expert knowledge to identify opportunities and solve the challenges its clients face.

www.cambridge-design.co.uk/
hello@cambridge-design.co.uk

Contact Abbie Meliniotis or Laura Cavaliere at CDP for more information:
lc1@cambridge-design.co.uk / avm@cambridge-design.co.uk /+44 (0) 1223 264428

Media contacts: Andrea Berghäll, EML Wildfire Technology PR
cdp@emlwildfire.com / +44 (0) 208 408 8000